Pro Health Tips
Tuesday, 1 December 2020
Combination Therapy Holds Promise in Resistant Liver Cancer
Regorafenib combined with an antibody treatment improved survival in mouse models of hepatocellular carcinoma.
from Medindia Health News https://ift.tt/37u8KaC
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Regorafenib combined with an antibody treatment improved survival in mouse models of hepatocellular carcinoma.
No comments:
Post a Comment